Photobiomodulation Improved the First Stages of Wound Healing Process After Abdominoplasty: An Experimental, Double-Blinded, Non-randomized Clinical Trial.


Journal

Aesthetic plastic surgery
ISSN: 1432-5241
Titre abrégé: Aesthetic Plast Surg
Pays: United States
ID NLM: 7701756

Informations de publication

Date de publication:
02 2019
Historique:
received: 15 08 2018
accepted: 09 11 2018
pubmed: 30 11 2018
medline: 4 4 2020
entrez: 29 11 2018
Statut: ppublish

Résumé

Photobiomodulation is widely studied for its potential benefits in the wound healing process. Numerous scientific studies have highlighted its effect on various phases of wound repair, but clinical validations are few. This comparative trial aims to evaluate the influence of photobiomodulation on the post-abdominoplasty healing process. Seventeen Caucasian women (aged 18-55) who underwent an abdominoplasty were enrolled in this double-blinded, controlled clinical trial. The postoperative scars were divided into two areas; the right side of the scars was treated with ten sessions of photobiomodulation (consisting in three types of wavelengths). The other part of the scars was used as control and did not receive any additional treatment. Clinical assessments of both parts of the scars were scheduled at 1, 6 and 12 months postoperative. Within six months following surgery, significantly improved quality of the scars on the treated side compared with the untreated side was reported by patients and experienced professionals according to Vancouver Scar Scale, Patient and Observer Scar Assessment Scale (p < 0.05) and standardized photographs (p < 0.05). At 1 year of follow-up, patients observed no differences between the treated and untreated sides of the scars. This suggests that photobiomodulation appears to play an early role in the wound healing process, accelerating the first stages of cicatrization. This study statistically validates the positive impact of photobiomodulation treatment on the first stages of the postoperative healing process. Carried out on Caucasians participants only, this study should, however, be performed on a more heterogeneous population to definitively confirm these effects on an international population. Registro Brasileiro de ensaios clínicos: http://www.ensaiosclinicos.gov.br , Trial RBR-49PK78. This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Sections du résumé

BACKGROUND
Photobiomodulation is widely studied for its potential benefits in the wound healing process. Numerous scientific studies have highlighted its effect on various phases of wound repair, but clinical validations are few. This comparative trial aims to evaluate the influence of photobiomodulation on the post-abdominoplasty healing process.
METHODS
Seventeen Caucasian women (aged 18-55) who underwent an abdominoplasty were enrolled in this double-blinded, controlled clinical trial. The postoperative scars were divided into two areas; the right side of the scars was treated with ten sessions of photobiomodulation (consisting in three types of wavelengths). The other part of the scars was used as control and did not receive any additional treatment. Clinical assessments of both parts of the scars were scheduled at 1, 6 and 12 months postoperative.
RESULTS
Within six months following surgery, significantly improved quality of the scars on the treated side compared with the untreated side was reported by patients and experienced professionals according to Vancouver Scar Scale, Patient and Observer Scar Assessment Scale (p < 0.05) and standardized photographs (p < 0.05). At 1 year of follow-up, patients observed no differences between the treated and untreated sides of the scars. This suggests that photobiomodulation appears to play an early role in the wound healing process, accelerating the first stages of cicatrization.
CONCLUSION
This study statistically validates the positive impact of photobiomodulation treatment on the first stages of the postoperative healing process. Carried out on Caucasians participants only, this study should, however, be performed on a more heterogeneous population to definitively confirm these effects on an international population.
CLINICAL TRIAL REGISTRY
Registro Brasileiro de ensaios clínicos: http://www.ensaiosclinicos.gov.br , Trial RBR-49PK78.
LEVEL OF EVIDENCE II
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Identifiants

pubmed: 30483937
doi: 10.1007/s00266-018-1271-2
pii: 10.1007/s00266-018-1271-2
doi:

Substances chimiques

Immunologic Factors 0

Banques de données

ReBec
['RBR-49PK78']

Types de publication

Comparative Study Controlled Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

147-154

Commentaires et corrections

Type : CommentIn

Auteurs

Renato Matta Ramos (RM)

Plastic Surgery Division of São Lucas Hospital of Pontificia, Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil. renatomatta82@hotmail.com.
Bliss Plastic Surgery, Private Clinic, Libertadores Street. 125. Postal Code: Lima 14, San Isidro Lima, Peru. renatomatta82@hotmail.com.

Marion Burland (M)

Biolux Institute, Phare de la méditerranée, 34250, Palavas Les Flots, Montpellier, France.
Inserm U1051, University of Montpellier, Montpellier, France.

Jefferson Braga Silva (JB)

Hand and Reconstructive Microsurgery Division of São Lucas Hospital of Pontificia, Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil.
School of Medicine, PUCRS University, Montpellier Cedex 5, Montpellier, France.

Lauren Marquardt Burman (LM)

Plastic Surgery Division of São Lucas Hospital of Pontificia, Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil.

Marco Smiderle Gelain (MS)

Universidade Federal de Ciências da Saúde de Porto Alegre, San Isidro, Lima, Peru.

Leticia Manoel Debom (LM)

Plastic Surgery Division of São Lucas Hospital of Pontificia, Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil.

Jean Michel Bec (JM)

Biolux Institute, Phare de la méditerranée, 34250, Palavas Les Flots, Montpellier, France.

Mohsen Alirezai (M)

Inserm U1051., INM, Hôpital St Eloi, University Hospital Center of Montpellier, 80 rue Augustin Fliche, 34091, Montpellier Cedex 5, France.

Carlos Oscar Uebel (CO)

Plastic Surgery Division of São Lucas Hospital of Pontificia, Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil.

Jean Valmier (J)

Inserm U1051, University of Montpellier, Montpellier, France.
Inserm U1051., INM, Hôpital St Eloi, University Hospital Center of Montpellier, 80 rue Augustin Fliche, 34091, Montpellier Cedex 5, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH